Fig. 7From: Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23BTX-A upregulated NEDD4 via inhibiting TLR2/MyD88 signaling. a and b Expression of NEDD4 gene and protein were measured using qRT-PCR and western blotting assay, respectively. c and d qRT-PCR and western blotting assay were carried out to examine expression of NEDD4 gene and protein. **P < 0.01 contrasted with Ctrl group, ##P < 0.01 contrasted with LPS group, and $$P < 0.01 compared with LPS + BTX-A groupBack to article page